Durvalumab (anti-PD-L1)Durvalumab (anti-PD-L1)
Move your mouse over image or click to enlarge

Durvalumab (anti-PD-L1)

Durvalumab (anti-PD-L1) is a selective, high affinity human IgG1 mAb that blocks programmed cell death ligand-1 (PD-L1) binding to PD-1 (IC50=0.1 nM) and CD80 (IC50=0.04 nM). MW=146.3 kDa.
Cat# Size Price Qty Buy
A2013-5mg 5mg £579.00

Additional Information

Property Value or Rating
Product Size 5mg
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2013

Related Documents